LeadArTech
礼达先导
LeadArTech (礼达先导) is a biotech company founded and led by CEO Ni Feng . BlueRun Ventures led its Pre-A round and has continued to back it, counting it among more than 200 portfolio companies . The firm's name appears in BlueRun's biotech salon coverage on drug discovery, suggesting it sits in the life-science or pharmaceutical-tools space .
elsewhere's corpus does not contain additional detail on its specific technology, funding size, or founding date.
AI-generated — may contain errors, please verify.
Coverage
Early Summer, Time to Surf to Your Heart's Content! | BlueRun Ventures Bi-Monthly Report
The thrill of surfing freely under a blazing sun.
The Future Looks Very Different | December & January Bimonthly Report
Witnessing BlueRun Ventures' "Defining Moment"
A Pill's Journey from Lab to Industry | BlueRun Ventures Biotech Salon Series
The investment logic in biotech has quietly shifted.
Be the change we want to see | BlueRun Ventures December Report
Memorable Moments from December
BlueRun Ventures Quarterly Investment & Funding Roundup | 2022 Q4
Sector distribution spans biotech and healthcare, enterprise services, hard tech, and new energy.
BlueRun Ventures Leads Nearly $6 Million Pre-A Round for Biotech Firm LeadXPro | BlueRun Ventures BlueRun Ventures led the Pre-A round for LeadXPro, a biotechnology company, raising nearly $6 million.
Building the world's largest database of human protein-probe interactions
Can Drug Discovery Move Beyond "Finding a Needle in a Haystack"? | BlueRun Ventures Biotech Salon Highlights
We spoke with DeepWise, Xinyue Biotech, Ketu Medicine, and Leadart Medtech about innovations in drug R&D models.
Beyond "Simple Models": A New Transformation in Drug R&D | BlueRun Ventures Bio-Tech Salon · Bio2X
This Saturday, June 25, BlueRun Ventures in conversation with DeepWise, Xinyue Biotech, Ketu Medicine, and Leadart Therapeutics
